119 related articles for article (PubMed ID: 37908048)
1. Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage abdominoperineal resection.
Hamza A; Masliah-Planchon J; Neuzillet C; Lefèvre JH; Svrcek M; Vacher S; Bourneix C; Delaye M; Goéré D; Dartigues P; Samalin E; Hilmi M; Lazartigues J; Girard E; Emile JF; Rigault E; Dangles-Marie V; Rioux-Leclercq N; de la Fouchardière C; Tougeron D; Casadei-Gardini A; Mariani P; Peschaud F; Cacheux W; Lièvre A; Bièche I
Int J Cancer; 2024 Feb; 154(3):504-515. PubMed ID: 37908048
[TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection.
Cacheux W; Rouleau E; Briaux A; Tsantoulis P; Mariani P; Richard-Molard M; Buecher B; Dangles-Marie V; Richon S; Lazartigues J; Jeannot E; Farkhondeh F; Sastre-Garau X; de La Rochefordière A; Labib A; Falcou MC; Stevens D; Roth A; Roman-Roman S; Mitry E; Bièche I; Lièvre A
Br J Cancer; 2016 Jun; 114(12):1387-94. PubMed ID: 27219019
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes.
Chung JH; Sanford E; Johnson A; Klempner SJ; Schrock AB; Palma NA; Erlich RL; Frampton GM; Chalmers ZR; Vergilio J; Rubinson DA; Sun JX; Chmielecki J; Yelensky R; Suh JH; Lipson D; George TJ; Elvin JA; Stephens PJ; Miller VA; Ross JS; Ali SM
Ann Oncol; 2016 Jul; 27(7):1336-41. PubMed ID: 27052656
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Genomic Profiling of Metastatic Squamous Cell Carcinoma of the Anal Canal.
Morris V; Rao X; Pickering C; Foo WC; Rashid A; Eterovic K; Kim T; Chen K; Wang J; Shaw K; Eng C
Mol Cancer Res; 2017 Nov; 15(11):1542-1550. PubMed ID: 28784613
[TBL] [Abstract][Full Text] [Related]
5. Molecular and immunophenotypic characterization of anal squamous cell carcinoma reveals distinct clinicopathologic groups associated with HPV and TP53 mutation status.
Zhu X; Jamshed S; Zou J; Azar A; Meng X; Bathini V; Dresser K; Strock C; Yalamarti B; Yang M; Tomaszewicz K; Tjionas G; Mochel MC; Hutchinson L; Bledsoe JR
Mod Pathol; 2021 May; 34(5):1017-1030. PubMed ID: 33483624
[TBL] [Abstract][Full Text] [Related]
6. Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma.
Mouw KW; Cleary JM; Reardon B; Pike J; Braunstein LZ; Kim J; Amin-Mansour A; Miao D; Damish A; Chin J; Ott PA; Fuchs CS; Martin NE; Getz G; Carter S; Mamon HJ; Hornick JL; Van Allen EM; D'Andrea AD
Clin Cancer Res; 2017 Jun; 23(12):3214-3222. PubMed ID: 27852700
[No Abstract] [Full Text] [Related]
7. KRAS, BRAF and PIK3CA status in squamous cell anal carcinoma (SCAC).
Casadei Gardini A; Capelli L; Ulivi P; Giannini M; Freier E; Tamberi S; Scarpi E; Passardi A; Zoli W; Ragazzini A; Amadori D; Frassineti GL
PLoS One; 2014; 9(3):e92071. PubMed ID: 24642661
[TBL] [Abstract][Full Text] [Related]
8. HPV-positive clinically advanced squamous cell carcinoma of the urinary bladder (aBSCC): A comprehensive genomic profiling (CGP) study.
Ghelani GH; Zerdan MB; Jacob J; Spiess PE; Li R; Necchi A; Grivas P; Kamat A; Danziger N; Lin D; Huang R; Decker B; Sokol ES; Cheng L; Pavlick D; Ross JS; Bratslavsky G; Basnet A
Urol Oncol; 2023 Dec; 41(12):486.e15-486.e23. PubMed ID: 37821306
[TBL] [Abstract][Full Text] [Related]
9. Salvage Abdominoperineal Resection for Anal Squamous Cell Carcinoma: Use, Risk Factors, and Outcomes in a Canadian Population.
Patel SV; Ko G; Raphael MJ; Booth CM; Brogly SB; Kalyvas M; Li W; Hanna T
Dis Colon Rectum; 2020 Jun; 63(6):748-757. PubMed ID: 32384405
[TBL] [Abstract][Full Text] [Related]
10. Genomic Landscape of Primary and Recurrent Anal Squamous Cell Carcinomas in Relation to HPV Integration, Copy-Number Variation, and DNA Damage Response Genes.
Aldersley J; Lorenz DR; Mouw KW; D'Andrea AD; Gabuzda D
Mol Cancer Res; 2021 Aug; 19(8):1308-1321. PubMed ID: 33883185
[TBL] [Abstract][Full Text] [Related]
11. A Systematic Review and Meta-Analysis of Prognostic Biomarkers in Anal Squamous Cell Carcinoma Treated With Primary Chemoradiotherapy.
Parwaiz I; MacCabe TA; Thomas MG; Messenger DE
Clin Oncol (R Coll Radiol); 2019 Dec; 31(12):e1-e13. PubMed ID: 31301958
[TBL] [Abstract][Full Text] [Related]
12. Mutation of chromatin regulators and focal hotspot alterations characterize human papillomavirus-positive oropharyngeal squamous cell carcinoma.
Haft S; Ren S; Xu G; Mark A; Fisch K; Guo TW; Khan Z; Pang J; Ando M; Liu C; Sakai A; Fukusumi T; Califano JA
Cancer; 2019 Jul; 125(14):2423-2434. PubMed ID: 30933315
[TBL] [Abstract][Full Text] [Related]
13. Activation of AKT and nuclear accumulation of wild type TP53 and MDM2 in anal squamous cell carcinoma.
Patel H; Polanco-Echeverry G; Segditsas S; Volikos E; McCart A; Lai C; Guenther T; Zaitoun A; Sieber O; Ilyas M; Northover J; Silver A
Int J Cancer; 2007 Dec; 121(12):2668-73. PubMed ID: 17721920
[TBL] [Abstract][Full Text] [Related]
14. TP53 and PIK3CA gene mutations in adenocarcinoma, squamous cell carcinoma and high-grade intraepithelial neoplasia of the cervix.
Tornesello ML; Annunziata C; Buonaguro L; Losito S; Greggi S; Buonaguro FM
J Transl Med; 2014 Sep; 12():255. PubMed ID: 25220666
[TBL] [Abstract][Full Text] [Related]
15. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.
Seiwert TY; Zuo Z; Keck MK; Khattri A; Pedamallu CS; Stricker T; Brown C; Pugh TJ; Stojanov P; Cho J; Lawrence MS; Getz G; Brägelmann J; DeBoer R; Weichselbaum RR; Langerman A; Portugal L; Blair E; Stenson K; Lingen MW; Cohen EE; Vokes EE; White KP; Hammerman PS
Clin Cancer Res; 2015 Feb; 21(3):632-41. PubMed ID: 25056374
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
[TBL] [Abstract][Full Text] [Related]
17. Molecular landscape of vulvovaginal squamous cell carcinoma: new insights into molecular mechanisms of HPV-associated and HPV-independent squamous cell carcinoma.
Salama AM; Momeni-Boroujeni A; Vanderbilt C; Ladanyi M; Soslow R
Mod Pathol; 2022 Feb; 35(2):274-282. PubMed ID: 34650187
[TBL] [Abstract][Full Text] [Related]
18. Reverse-phase protein array profiling of oropharyngeal cancer and significance of PIK3CA mutations in HPV-associated head and neck cancer.
Sewell A; Brown B; Biktasova A; Mills GB; Lu Y; Tyson DR; Issaeva N; Yarbrough WG
Clin Cancer Res; 2014 May; 20(9):2300-11. PubMed ID: 24599934
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of pAKT(Ser473) expression in progression of HPV-positive oropharyngeal squamous cell carcinoma.
Horn D; Freudlsperger C; Holzinger D; Kunzmann K; Plinkert P; Dyckhoff G; Hoffmann J; Freier K; Hess J
Head Neck; 2017 Dec; 39(12):2397-2405. PubMed ID: 28945300
[TBL] [Abstract][Full Text] [Related]
20. Molecular events in the pathogenesis of vulvar squamous cell carcinoma.
Xing D; Fadare O
Semin Diagn Pathol; 2021 Jan; 38(1):50-61. PubMed ID: 33032902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
